MILLER STRATEGIES, LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · represents biopharmaceutical research companies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $60,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.